The STEP-1 trial on semaglutide showed that nearly 40% of weight lost came from lean mass
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
Toxicology and Industrial Health
Recommended Add in: Zinc, NAD, Vitamin D Best for: Frequent flyers and business travelers, vacationers adjusting to new time zones, professionals needing peak performance post-flight DETOX & CELLULAR HEALTH Clean Sweep $210 A powerful, liver-supportive IV therapy designed especially for individuals with MTHFR gene variations or anyone seeking deep cellular detox
